Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insmed
Pharma
Insmed plots key expansion for Arikayce on new data
Insmed has revealed results from a trial of Arikayce, which could pave the way for a significant label expansion for the lung disease drug.
Kevin Dunleavy
Mar 23, 2026 11:21am
Insmed forecasts sales of Brinsupri will reach $1B in 2026
Feb 19, 2026 11:45am
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls
Jan 12, 2026 11:25pm
Upside for Insmed after Brinsupri’s first-in-class sales beat
Jan 9, 2026 10:40am
Insmed's Brinsupri comes up short in rhinosinusitis trial
Dec 18, 2025 11:27am
United shares surge on Tyvaso win in new lung disease population
Sep 2, 2025 3:34pm
